Cancer treatment-related xerostomia: basics, therapeutics, and future perspectives.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 9517857 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-783X (Electronic) Linking ISSN: 09492321 NLM ISO Abbreviation: Eur J Med Res Subsets: MEDLINE
    • Publication Information:
      Publication: Jan. 2012- : London : BioMed Central
      Original Publication: Munich, Germany : I. Holzapfel, c1995-
    • Subject Terms:
    • Abstract:
      Xerostomia, generally addressed as dry mouth, poses significant challenges to patients' quality of life, particularly in the context of cancer treatment. Although various medications and interventions, including salivary substitutes and stimulants, muscarinic agonists, antineoplastic detoxifying agents, anti-inflammatory agents, superoxide dismutase mimetics, mesenchymal stem cells, submandibular gland transfer, intensity-modulated radiation therapy, dose fractionation, transcutaneous electrical nerve stimulation, hyperbaric oxygen therapy, photobiomodulation, acupuncture, and nutritional interventions, have been proposed for this condition, no approved or definite treatments are currently available. Moreover, the evidence supporting the efficacy of proposed interventions remains limited and subject to controversy in terms of safety, efficacy, and optimal protocol. This review provides a comprehensive insight into cancer treatment-related xerostomia, underlying its pathophysiology, etiology, clinical manifestation, and therapeutic options, providing a clinical guide for clinicians to adopt a patient-tailored approach to cancer treatment-related xerostomia and offering vision on current ongoing and future studies in the field.
      Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The lead author is currently an associate editor of the European Journal of Medical Research. The authors declare no other competing interests.
      (© 2024. The Author(s).)
    • References:
      Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):237-244. (PMID: 33095141)
      Otolaryngol Head Neck Surg. 2016 Sep;155(3):423-30. (PMID: 27048670)
      Int J Mol Sci. 2021 Aug 18;22(16):. (PMID: 34445613)
      J Texture Stud. 2021 Apr;52(2):141-156. (PMID: 33274753)
      Altern Ther Health Med. 2012 Jul-Aug;18(4):12-8. (PMID: 22875590)
      Front Pharmacol. 2018 Apr 24;9:394. (PMID: 29740320)
      Drug Des Devel Ther. 2021 Mar 05;15:1021-1029. (PMID: 33716500)
      Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Jul;130(1):52-62. (PMID: 32444333)
      Sci Transl Med. 2021 May 12;13(593):. (PMID: 33980575)
      J Clin Exp Dent. 2015 Feb 01;7(1):e13-7. (PMID: 25810824)
      Med Gas Res. 2013 Jul 02;3(1):15. (PMID: 23816249)
      Ann Palliat Med. 2020 May;9(3):1340-1350. (PMID: 32279510)
      PLoS One. 2008 Apr 30;3(4):e2063. (PMID: 18446241)
      J Natl Med Assoc. 2024 Jan 19;:. (PMID: 38326141)
      J Cancer Res Clin Oncol. 2023 May;149(5):1785-1810. (PMID: 35731274)
      Radiat Oncol. 2020 Apr 28;15(1):90. (PMID: 32345309)
      Drugs. 2001;61(5):641-84. (PMID: 11368288)
      Support Care Cancer. 2020 Jun;28(6):2817-2828. (PMID: 31732852)
      Oral Radiol. 2021 Jul;37(3):531-536. (PMID: 32893314)
      Radiat Oncol. 2014 Feb 21;9:62. (PMID: 24555575)
      Clin Oncol (R Coll Radiol). 2009 Dec;21(10):737-44. (PMID: 19833490)
      J Oral Rehabil. 2018 Sep;45(9):730-746. (PMID: 29878444)
      Oral Dis. 2013 May;19(4):327-46. (PMID: 23107104)
      Clin Oncol (R Coll Radiol). 2019 Dec;31(12):850-857. (PMID: 31296457)
      J Oncol. 2022 Aug 27;2022:7802334. (PMID: 36065305)
      J Integr Med. 2017 May;15(3):201-208. (PMID: 28494850)
      Lasers Med Sci. 2023 Apr 15;38(1):101. (PMID: 37060370)
      CA Cancer J Clin. 2012 Nov-Dec;62(6):400-22. (PMID: 22972543)
      Support Care Cancer. 2023 Oct 18;31(12):644. (PMID: 37851095)
      Clin Dermatol. 2017 Sep - Oct;35(5):468-476. (PMID: 28916028)
      J Photochem Photobiol B. 2020 Aug;209:111933. (PMID: 32570059)
      Radiother Oncol. 2022 Oct;175:1-9. (PMID: 35817320)
      Oral Dis. 2021 Jul;27(5):1115-1126. (PMID: 32964596)
      Crit Rev Oncol Hematol. 2022 Dec;180:103826. (PMID: 36191821)
      Spec Care Dentist. 2013 May-Jun;33(3):123-7. (PMID: 23600983)
      Arch Otolaryngol Head Neck Surg. 2005 Feb;131(2):140-5. (PMID: 15723946)
      J Cell Biol. 2018 Jun 4;217(6):1915-1928. (PMID: 29669742)
      Ann Med Health Sci Res. 2014 Jul;4(4):503-10. (PMID: 25221694)
      Aust Dent J. 2010 Sep;55(3):238-44; quiz 353. (PMID: 20887509)
      Head Neck. 2023 Apr;45(4):1026-1044. (PMID: 36779370)
      J Cancer Res Clin Oncol. 2015 Nov;141(11):1985-94. (PMID: 25910988)
      Oral Dis. 2019 Nov;25(8):1937-1944. (PMID: 31520497)
      Adv Exp Med Biol. 2021;1342:399-416. (PMID: 34972977)
      Mediators Inflamm. 2014;2014:518261. (PMID: 24757285)
      J Appl Clin Med Phys. 2018 May;19(3):251-260. (PMID: 29664218)
      Antioxidants (Basel). 2023 Mar 12;12(3):. (PMID: 36978952)
      Homeopathy. 2005 Jul;94(3):175-81. (PMID: 16060203)
      J Transl Med. 2023 Oct 9;21(1):708. (PMID: 37814303)
      In Vivo. 2013 Nov-Dec;27(6):869-71. (PMID: 24292594)
      Head Neck. 2023 Sep;45(9):2198-2206. (PMID: 37403447)
      Int J Mol Sci. 2023 Mar 10;24(6):. (PMID: 36982432)
      In Vivo. 2022 Nov-Dec;36(6):2579-2597. (PMID: 36309356)
      Eur J Oncol Nurs. 2018 Jun;34:89-97. (PMID: 29784145)
      Aust Dent J. 2011 Sep;56(3):290-5. (PMID: 21884145)
      Front Oral Health. 2022 Jun 09;3:907778. (PMID: 35757443)
      Curr Oncol. 2023 Apr 24;30(5):4412-4426. (PMID: 37232794)
      Cytotherapy. 2023 Nov;25(11):1139-1144. (PMID: 37589639)
      Radiat Oncol J. 2020 Jun;38(2):84-92. (PMID: 33012151)
      Eur Arch Otorhinolaryngol. 2024 Jun;281(6):2793-2805. (PMID: 38189964)
      Head Neck. 2002 Aug;24(8):737-47. (PMID: 12203798)
      Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jul;120(1):22-8. (PMID: 26093680)
      Cancers (Basel). 2022 Dec 30;15(1):. (PMID: 36612247)
      Ther Clin Risk Manag. 2015 Feb 04;11:171-88. (PMID: 25691810)
      Pharmaceuticals (Basel). 2022 Jun 18;15(6):. (PMID: 35745681)
      Lancet Oncol. 2011 Feb;12(2):127-36. (PMID: 21236730)
      Oncologist. 2007 Jun;12(6):738-47. (PMID: 17602063)
      BMC Oral Health. 2022 Dec 1;22(1):548. (PMID: 36457091)
      Sci Rep. 2017 Jun 13;7(1):3369. (PMID: 28611366)
      Oncologist. 2019 Sep;24(9):1259-1269. (PMID: 30996010)
      J Cancer Res Clin Oncol. 2023 May;149(5):2057-2070. (PMID: 35870011)
      Arch Oral Biol. 2015 Feb;60(2):242-55. (PMID: 25463902)
      Cochrane Database Syst Rev. 2017 Jul 31;7:CD012744. (PMID: 28759701)
      Curr Probl Cancer. 2016 Sep - Dec;40(5-6):244-257. (PMID: 27520848)
      Integr Cancer Ther. 2013 May;12(3):197-205. (PMID: 22791311)
      Sao Paulo Med J. 2021 Jul-Aug;139(4):380-387. (PMID: 34190871)
      J Clin Med. 2020 Dec 18;9(12):. (PMID: 33353023)
      Pharmaceuticals (Basel). 2023 Aug 10;16(8):. (PMID: 37631049)
      Ann Oncol. 2013 Mar;24(3):776-83. (PMID: 23104718)
      J Am Dent Assoc. 2003 Jan;134(1):61-9; quiz 118-9. (PMID: 12555958)
      Ann Med Surg (Lond). 2021 Feb 03;63:102146. (PMID: 33664943)
      Med Hypotheses. 2010 Jan;74(1):29-30. (PMID: 19729251)
      Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):220-7. (PMID: 25841622)
      JAMA Oncol. 2023 Aug 1;9(8):1056-1064. (PMID: 37261806)
      Radiother Oncol. 2021 Jul;160:32-39. (PMID: 33839202)
      Cancer. 2012 Jul 1;118(13):3337-44. (PMID: 22072272)
      Support Care Cancer. 2022 Feb;30(2):1681-1687. (PMID: 34562169)
      Sci Rep. 2022 May 19;12(1):8419. (PMID: 35589816)
      Cancers (Basel). 2022 Jul 11;14(14):. (PMID: 35884440)
      Int J Otolaryngol. 2020 Aug 06;2020:8537643. (PMID: 32952561)
      Int Dent J. 2021 Feb;71(1):9-20. (PMID: 33616057)
      Am J Ophthalmol. 2021 Jul;227:25-34. (PMID: 33626365)
      Nutrients. 2022 Oct 16;14(20):. (PMID: 36297013)
      In Vivo. 2020 Mar-Apr;34(2):623-629. (PMID: 32111762)
      Oral Oncol. 2017 Mar;66:64-74. (PMID: 28249650)
      J Oral Rehabil. 2014 Mar;41(3):226-35. (PMID: 24527846)
      Asia Pac J Oncol Nurs. 2021 Oct 04;8(6):604-609. (PMID: 34790844)
      Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 May;117(5):595-607. (PMID: 24650370)
      Int Dent J. 2011 Dec;61(6):287-96. (PMID: 22117784)
      Pharmaceuticals (Basel). 2022 Feb 16;15(2):. (PMID: 35215344)
      J Dent. 2019 Jan;80 Suppl 1:S3-S12. (PMID: 30696553)
      Fed Pract. 2020 May;37(5):234-241. (PMID: 32454578)
      Int J Clin Pract. 2010 Feb;64(3):404-7. (PMID: 19817913)
      Oral Oncol. 2011 Jun;47(6):546-51. (PMID: 21493124)
      Redox Biol. 2020 Jul;34:101542. (PMID: 32361681)
      Mol Pharmacol. 2017 Nov;92(5):601-612. (PMID: 28893976)
      Lasers Med Sci. 2017 May;32(4):827-832. (PMID: 28258315)
      J Clin Med. 2023 Jul 10;12(14):. (PMID: 37510706)
      Expert Rev Mol Diagn. 2021 Jul;21(7):641-654. (PMID: 34024238)
      J Oral Rehabil. 2019 Dec;46(12):1142-1150. (PMID: 31251407)
      Cancer. 2021 Jun 1;127(11):1796-1804. (PMID: 33595843)
      J Med Imaging Radiat Oncol. 2018 Dec;62(6):841-846. (PMID: 30113763)
      Am J Health Syst Pharm. 2013 Jun 15;70(12):1025-32. (PMID: 23719879)
      Nutrients. 2021 Nov 25;13(12):. (PMID: 34959787)
      Stem Cells Transl Med. 2022 May 27;11(5):478-489. (PMID: 35435231)
      Front Oral Health. 2022 Aug 11;3:968157. (PMID: 36060116)
      Physiol Int. 2020 Jul 24;107(2):195-208. (PMID: 32750027)
      Arch Oral Biol. 2019 Sep;105:20-26. (PMID: 31238198)
      J Family Med Prim Care. 2022 Feb;11(2):767-771. (PMID: 35360757)
      Polymers (Basel). 2022 Feb 22;14(5):. (PMID: 35267672)
      J BUON. 2010 Jul-Sep;15(3):475-9. (PMID: 20941813)
      Int J Dent Hyg. 2009 May;7(2):126-30. (PMID: 19416095)
      JAMA Netw Open. 2019 Dec 2;2(12):e1916910. (PMID: 31808921)
      J Pediatr Hematol Oncol. 2017 Nov;39(8):e437-e442. (PMID: 28816803)
      Exp Mol Pathol. 2020 Feb;112:104324. (PMID: 31697930)
      Eur J Pharmacol. 2008 Apr 7;583(2-3):322-39. (PMID: 18295199)
      Photobiomodul Photomed Laser Surg. 2020 Jun;38(6):340-347. (PMID: 32109187)
      Int J Prosthodont. 2016 Sep-Oct;29(5):455-60. (PMID: 27611748)
      Front Oncol. 2022 Aug 09;12:949071. (PMID: 36016616)
      Medicine (Baltimore). 2022 Nov 18;101(46):e31761. (PMID: 36401365)
      Int J Dermatol. 2010 Mar;49(3):239-48. (PMID: 20465658)
      J Oral Rehabil. 2017 Nov;44(11):889-895. (PMID: 28741683)
      Braz Oral Res. 2017 Jan 16;31:e14. (PMID: 28099580)
      Head Neck. 2016 Apr;38 Suppl 1:E1232-7. (PMID: 26315309)
    • Contributed Indexing:
      Keywords: Cancer treatment-associated xerostomia; Cancer-related salivary dysfunction; Head and neck cancer; Muscarinic agonists; Palliative care; Radiotherapy; Xerostomia
    • Accession Number:
      0 (Antineoplastic Agents)
    • Publication Date:
      Date Created: 20241129 Date Completed: 20241130 Latest Revision: 20241210
    • Publication Date:
      20241210
    • Accession Number:
      PMC11607820
    • Accession Number:
      10.1186/s40001-024-02167-x
    • Accession Number:
      39614391